A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.
Study Details
Study Description
Brief Summary
The purpose of this study is to examine the safety and tolerability of ZDV when given to premature infants born to HIV-positive women to prevent HIV infection.
ZDV has been used successfully to prevent the transmission of HIV from mother to child during pregnancy and birth. However, ZDV has been given to very few premature babies, and the best dose to use has not yet been determined.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
N/A |
Detailed Description
In the preliminary group of premature infants, those receiving q 6h dosing had an average trough concentration of 7.3 uM (18%). However, the premature infants in the preliminary pharmacokinetic study did not have long term follow-up to assess toxicity. Due to the potential for altered ZDV pharmacokinetics and increased toxicity in this population, an evaluation of ZDV pharmacokinetics in premature infants is proposed.
Premature infants less than or equal to 34 weeks gestational age at birth and begun on ZDV by their clinical caregivers will be entered into the protocol within the first 5 days of life. Upon entry, ZDV will be administered every 12 hours intravenously or orally. The study will require 9 serum samples for ZDV assay collected over 30 days, some additional clinical laboratory tests collected over 12 weeks, collection of 3 spot urine samples, and collection of routine clinical data.
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria
Your baby may be eligible for this study if he/she:
-
Requires ZDV (as decided by your doctor) because you are HIV-positive.
-
Is 1-5 days old and was born prematurely.
Exclusion Criteria
Your baby will not be eligible for this study if he/she:
-
Is not expected to live 6 weeks because of severe illness.
-
Is having problems with blood pressure or is not urinating enough.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Univ of Alabama at Birmingham - Pediatric | Birmingham | Alabama | United States | 35233 |
2 | Phoenix Childrens Hosp | Phoenix | Arizona | United States | 85006 |
3 | UCSD Med Ctr / Pediatrics / Clinical Sciences | La Jolla | California | United States | 920930672 |
4 | Los Angeles County - USC Med Ctr | Los Angeles | California | United States | 90033 |
5 | UCLA Med Ctr / Pediatric | Los Angeles | California | United States | 900951752 |
6 | Harbor - UCLA Med Ctr / UCLA School of Medicine | Los Angeles | California | United States | 905022004 |
7 | Children's Hosp of Oakland | Oakland | California | United States | 946091809 |
8 | San Francisco Gen Hosp | San Francisco | California | United States | 94110 |
9 | UCSF / Moffitt Hosp - Pediatric | San Francisco | California | United States | 941430105 |
10 | Univ of Florida Gainesville | Gainesville | Florida | United States | 32610 |
11 | Univ of Florida Health Science Ctr / Pediatrics | Jacksonville | Florida | United States | 32209 |
12 | Univ of Miami / Jackson Memorial Hosp | Miami | Florida | United States | 33136 |
13 | Univ of Miami (Pediatric) | Miami | Florida | United States | 33161 |
14 | Emory Univ Hosp / Pediatrics | Atlanta | Georgia | United States | 30306 |
15 | Univ of Illinois College of Medicine / Pediatrics | Chicago | Illinois | United States | 60612 |
16 | Univ of Chicago Children's Hosp | Chicago | Illinois | United States | 606371470 |
17 | Division of Inf Diseases/ Indiana Univ Hosp | Indianapolis | Indiana | United States | 46202 |
18 | Children's Hosp of Boston | Boston | Massachusetts | United States | 021155724 |
19 | Boston City Hosp / Pediatrics | Boston | Massachusetts | United States | 02118 |
20 | Univ of Massachusetts Med School | Worcester | Massachusetts | United States | 016550001 |
21 | Univ of Mississippi Med Ctr | Jackson | Mississippi | United States | 39213 |
22 | Univ of Medicine & Dentistry of New Jersey / Univ Hosp | Newark | New Jersey | United States | 071032714 |
23 | Children's Hosp at Albany Med Ctr | Albany | New York | United States | 12208 |
24 | Columbia Presbyterian Med Ctr | New York | New York | United States | 10032 |
25 | Harlem Hosp Ctr | New York | New York | United States | 10037 |
26 | Univ of Rochester Med Ctr | Rochester | New York | United States | 146420001 |
27 | State Univ of New York at Stony Brook | Stony Brook | New York | United States | 117948111 |
28 | SUNY Health Sciences Ctr at Syracuse / Pediatrics | Syracuse | New York | United States | 13210 |
29 | Westchester Hosp | Valhalla | New York | United States | 10595 |
30 | Duke Univ Med Ctr | Durham | North Carolina | United States | 277103499 |
31 | Med Univ of South Carolina | Charleston | South Carolina | United States | 294253312 |
32 | Children's Med Ctr of Dallas | Dallas | Texas | United States | 75235 |
33 | Children's Hosp of the King's Daughters | Norfolk | Virginia | United States | 23507 |
34 | Med College of Virginia | Richmond | Virginia | United States | 23219 |
35 | Children's Hospital & Medical Center / Seattle ACTU | Seattle | Washington | United States | 981050371 |
36 | Univ of Puerto Rico / Univ Children's Hosp AIDS | San Juan | Puerto Rico | 009365067 |
Sponsors and Collaborators
- National Institute of Allergy and Infectious Diseases (NIAID)
Investigators
- Study Chair: Mirochnick M,
- Study Chair: Dankner D,
- Study Chair: Capparelli E,
Study Documents (Full-Text)
None provided.More Information
Publications
- ACTG 331
- 11303